Immutep Limited (IMMP) Cash Flow Statement

NASDAQ: IMMPOperating cash, capex, free cash flow and buybacks.

Where IMMP’s cash came from and went, FY2026

June 30, 2026 · Australian dollars
Cash from operations
−A$54.3M
Capital expenditures
A$90,895
0.6% of revenue
Free cash flow
−A$54.3M
−381.7% margin
Returned to shareholders
—
Change in cash
A$5.1M
cash at year-end A$68.9M
Investments (net): A$56.6MInvestments (net)A$56.6MCurrency & other: A$4.1MCurrency & otherA$4.1MCash used in operations: A$54.3MCash used in operationsA$54.3M · 89%Added to cash: A$5.1MAdded to cashA$5.1M · 8%Acquisitions & other, Capital expenditures: A$1.4MOther usesA$1.4M · 2%A$60.7M
Cash from operations
−A$54.3M
Investments (net)
+A$56.6M
Acquisitions & other
−A$1.3M
Currency & other
+A$4.0M
Change in cash
A$5.1M

Drawn to scale: where the cash came from and how it was used. Hover for values.

IMMP operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

IMMP cash flow trends, FY2017–FY2026

Immutep Limited cash flow trends
MetricTrendThenLatestChange
Operating cash flow−A$8.5MFY2017−A$54.3MFY2026—
Capital expendituresA$6,644FY2017A$90,895FY2026+33.7%/yr
Free cash flow−A$8.5MFY2017−A$54.3MFY2026—
Free cash flow margin−201.7%FY2017−381.7%FY2026−180.0 pts
Stock-based compensationA$862,227FY2017A$1.2MFY2025+3.8%/yr
Dividends paidA$0FY2017A$0FY2023—
Share buybacks (net)A$0FY2017A$0FY2019—
Capex / revenue0.2%FY20170.6%FY2026+0.5 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

IMMP cash flow by activity

OperatingInvestingFinancingChange in cash

IMMP net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

IMMP cash flow statement in Australian dollars

Immutep Limited annual cash flow statement
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating activities
Net income−A$77.6M−A$61.4M−A$42.7M−A$39.9M−A$32.2M−A$29.9M−A$13.5M−A$18.3M−A$12.7M−A$9.4M
Depreciation & amortizationA$2.4MA$2.5MA$2.2MA$2.0MA$2.1MA$2.0MA$2.1MA$1.9MA$1.8MA$1.7M
Stock-based compensation—A$1.2MA$1.8MA$2.0MA$1.5MA$1.7MA$1.7MA$1.6MA$2.3MA$862,227
Change in working capitalA$16.2M−A$8.5MA$3.5MA$764,596−A$1.6M−A$2.0MA$94,163−A$345,187−A$252,216−A$2.2M
Other non-cash itemsA$4.7MA$4.3MA$469,352−A$782,889−A$9,046A$10.5M−A$1.3M−A$58,365A$1.1MA$533,249
Cash from operating activities−A$54.3M−A$62.0M−A$34.8M−A$35.9M−A$30.2M−A$17.6M−A$10.8M−A$15.3M−A$7.8M−A$8.5M
Investing activities
Capital expenditures−A$90,895−A$45,769−A$932,369−A$47,000−A$22,914−A$15,601−A$19,348−A$41,434−A$11,893−A$6,644
Investments (net)A$56.6M—−A$21.0M−A$31,000−A$45,000−A$24,000−A$19,348−A$41,434−A$11,893−A$6,644
Acquisitions & other investing−A$1.3M−A$38.5MA$932,369A$47,000A$45,000A$24,000A$19,348A$41,434A$11,893A$6,644
Cash from investing activitiesA$55.2M−A$38.5M−A$21.0M−A$31,000−A$22,914−A$15,601−A$19,348−A$41,434−A$11,893−A$6,644
Financing activities
Dividends paid———A$0A$0—A$0A$0A$0A$0
Share repurchases & issuance (net)———————A$8.8MA$19.7MA$0
Net borrowing (repayment)−A$214,424—−A$226,494−A$211,974−A$222,536−A$214,378−A$77,541−A$77,541−A$77,541−A$77,541
Shares issuedA$0A$0A$100.2MA$80.1MA$53.0MA$43.3MA$22.0MA$4.9MA$0A$0
Other financingA$4,687−A$525,121−A$4.8M−A$3.8M−A$2.4MA$9.6M−A$1.5M−A$5.6M−A$1.2MA$69,009
Cash from financing activities−A$209,737−A$525,121A$95.2MA$76.0MA$50.3MA$52.7MA$20.5MA$8.0MA$18.4M−A$8,532
Summary
Net change in cashA$5.1M−A$94.4MA$38.4MA$43.4MA$19.4MA$34.3MA$9.8M−A$6.9MA$11.2M−A$8.6M
Cash at end of periodA$68.9MA$67.4MA$161.8MA$123.4MA$80.0MA$60.6MA$26.3MA$16.6MA$23.5MA$12.2M
Free cash flow−A$54.3M−A$62.1M−A$35.8M−A$35.9M−A$30.3M−A$17.7M−A$10.9M−A$15.3M−A$7.8M−A$8.5M
Free cash flow margin−381.7%−1,231.1%−930.6%−1,024.9%−17,757.1%−457.1%−145.0%−10,965.5%−296.1%−201.7%
Capex / revenue0.6%0.9%24.3%1.3%13.4%0.4%0.3%29.6%0.5%0.2%

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in Australian dollars as reported; data from EODHD.

IMMP cash generation

In fiscal 2026 (ended June 30, 2026), Immutep generated -A$54.3 million of cash from operations and spent A$0.1 million on capital expenditures, leaving free cash flow of -A$54.3 million, −381.7% of revenue. Cash and equivalents rose by A$5.1 million over the year.

Related: IMMP income statement, IMMP balance sheet. See the IMMP stock overview for the latest quote and news.

IMMP cash flow FAQ

What is Immutep's free cash flow?

Immutep's free cash flow was -A$54.3 million in fiscal 2026: -A$54.3 million of operating cash flow minus A$0.1 million of capital expenditures It was -A$62.1 million a year earlier..

How much cash does Immutep generate from operations?

Immutep generated -A$54.3 million of cash from operating activities in fiscal 2026.

How much does Immutep spend on capital expenditures?

Immutep spent A$0.1 million on capital expenditures in fiscal 2026, 0.6% of revenue, compared with A$0.0 million the year before.

Biotechnology: cash flow